Related references
Note: Only part of the references are listed.Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
Cynthia Rodriguez-Nava et al.
BIOMEDICINES (2023)
Roles of Podoplanin in Malignant Progression of Tumor
Hiroyuki Suzuki et al.
CELLS (2022)
Podoplanin Expression Independently and Jointly with Oral Epithelial Dysplasia Grade Acts as a Potential Biomarker of Malignant Transformation in Oral Leukoplakia
Luis Monteiro et al.
BIOMOLECULES (2022)
Podoplanin could be a predictive biomarker of the risk of patients with oral leukoplakia to develop oral cancer: A systematic review and meta-analysisKeywords
Luis Monteiro et al.
ORAL DISEASES (2022)
Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and Transformation Into Oral Cancer
Pratima Kumari et al.
FRONTIERS IN PHARMACOLOGY (2022)
Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways
Kelly L. Hamilton et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment
Byeong-Oh Hwang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies
Luigi Lorini et al.
CANCERS (2021)
Oral potentially malignant disorders: A comprehensive review on clinical aspects and management
Saman Warnakulasuriya
ORAL ONCOLOGY (2020)
Podoplanin is indispensable for cell motility and platelet-induced epithelial-to-mesenchymal transition-related gene expression in esophagus squamous carcinoma TE11A cells
Nobuo Watanabe et al.
CANCER CELL INTERNATIONAL (2020)
Podoplanin as an Attractive Target of CAR T Cell Therapy
Masazumi Waseda et al.
CELLS (2020)
Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis
Silvio Abati et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Podoplanin in Inflammation and Cancer
Miguel Quintanilla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Podoplanin expression in oral leukoplakia-a prospective study
Kathrin J. Grochau et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2019)
Structure-function and application of plant lectins in disease biology and immunity
Abtar Mishra et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities
Sattva S. Neelapu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Podoplanin: An emerging cancer biomarker and therapeutic target
Harini Krishnan et al.
CANCER SCIENCE (2018)
Podoplanin emerges as a functionally relevant oral cancer biomarker and therapeutic target
Edward P. Retzbach et al.
ORAL ONCOLOGY (2018)
Oral potentially malignant disorders: risk of progression to malignancy
Paul M. Speight et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2018)
C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice
T. Shirai et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
Juliane Gust et al.
CANCER DISCOVERY (2017)
Oral Field Cancerization and Its Clinical Implications in the Management in Potentially Malignant Disorders
Anisha Cynthia Sathiasekar et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2017)
Platelet-activating factor podoplanin: from discovery to drug development
Ai Takemoto et al.
CANCER AND METASTASIS REVIEWS (2017)
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
David T. Teachey et al.
CANCER DISCOVERY (2016)
CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains
Satoshi Shiina et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Symptom management during and after treatment with concurrent chemoradiotherapy for oropharyngeal cancer: A review of the literature and areas for future research
Heidi Mason et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2016)
Lectins with Potential for Anti-Cancer Therapy
Tammy Yau et al.
MOLECULES (2015)
Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis
Yao-Wen Chang et al.
ONCOTARGET (2015)
Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms
Jhon A. Ochoa-Alvarez et al.
ONCOTARGET (2015)
Expression of podoplanin in different grades of oral squamous cell carcinoma
B. Prasad et al.
ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH (2015)
Mechanistic explanation for platelet contribution to cancer metastasis
David Stegner et al.
THROMBOSIS RESEARCH (2014)
A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin
Yukinari Kato et al.
SCIENTIFIC REPORTS (2014)
Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development
Jin-Qiu Feng et al.
ORAL ONCOLOGY (2012)
Plant Lectin Can Target Receptors Containing Sialic Acid, Exemplified by Podoplanin, to Inhibit Transformed Cell Growth and Migration
Jhon Alberto Ochoa-Alvarez et al.
PLOS ONE (2012)
Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity
Harumi Inoue et al.
TUMOR BIOLOGY (2012)
Podoplanin: emerging functions in development the immune system and cancer
Jillian L. Astarita et al.
FRONTIERS IN IMMUNOLOGY (2012)
Enhanced Expression of Podoplanin in Oral Carcinomas in situ and Squamous Cell Carcinomas
Akinori Funayama et al.
PATHOBIOLOGY (2011)
Deadly allies: the fatal interplay between platelets and metastasizing cancer cells
Luise Erpenbeck et al.
BLOOD (2010)
Podoplanin and ABCG2: Malignant Transformation Risk Markers for Oral Lichen Planus
Peng Shi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations
Matthias Kreppel et al.
VIRCHOWS ARCHIV (2010)
Global epidemiology of oral and oropharyngeal cancer
Saman Warnakulasuriya
ORAL ONCOLOGY (2009)
A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus
Y. R. Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2008)
Characterization of anti-podoplanin monoclonal antibodies: Critical epitopes for neutralizing the interaction between podoplanin and CLEC-2
Satoshi Ogasawara et al.
HYBRIDOMA (2008)
Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain
Yukinari Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition
Ester Martin-Villar et al.
JOURNAL OF CELL SCIENCE (2006)
Overexpression of podoplanin in oral cancer and its association with poor clinical outcome
Ping Yuan et al.
CANCER (2006)
Antinutritional properties of plant lectins
IM Vasconcelos et al.
TOXICON (2004)